首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial ISRCTN45683816
【2h】

Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial ISRCTN45683816

机译:番红花和丙咪嗪治疗轻度至中度抑郁症的比较:一项先导性双盲随机试验ISRCTN45683816

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe morbidity and mortality associated with depression are considerable and continue to increase. Depression currently ranks fourth among the major causes of disability worldwide, after lower respiratory infections, prenatal conditions, and HIV/AIDS. Crocus sativus L. is used to treat depression. Many medicinal plants textbooks refer to this indication whereas there is no evidence-based document. Our objective was to compare the efficacy of stigmas of Crocus sativus (saffron) with imipramine in the treatment of mild to moderate depression in a 6-week pilot double-blind randomized trial.
机译:背景技术与抑郁症相关的发病率和死亡率是相当大的,并且还在继续增加。在下呼吸道感染,产前状况和艾滋病毒/艾滋病之后,抑郁症目前在全球残疾的主要原因中排名第四。番红花被用来治疗抑郁症。许多药用植物教科书都提到了这种适应症,而没有基于证据的文献。我们的目标是在一项为期6周的双盲先导随机试验中,比较番红花柱头(藏红花)和丙米嗪对轻度至中度抑郁症的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号